arrow_back Civic Audit
Share share

Medicare Opioid Addiction Treatment: Outreach and Awareness

This act aims to improve access to opioid addiction treatment for Medicare beneficiaries. It mandates outreach campaigns for both healthcare providers and patients to ensure awareness of available services and eligibility requirements. This will help more people receive the necessary support for opioid use disorder.
Key points
Doctors and other medical professionals will receive comprehensive information on how to bill for and provide opioid use disorder treatment services under Medicare.
Medicare beneficiaries will be informed that opioid use disorder treatment is a covered benefit and what the eligibility requirements are.
The government will regularly report on the effectiveness of these outreach efforts and the number of people receiving treatment, allowing for impact assessment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_8884
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2022-09-19
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Medicare Opioid Use Disorder Outreach Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8884.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-09-19.

What are the main provisions?

Key points include:

  • Doctors and other medical professionals will receive comprehensive information on how to bill for and provide opioid use disorder treatment services under Medicare.
  • Medicare beneficiaries will be informed that opioid use disorder treatment is a covered benefit and what the eligibility requirements are.
  • The government will regularly report on the effectiveness of these outreach efforts and the number of people receiving treatment, allowing for impact assessment.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health